Marksans Pharma Limited

MARKSANSNSE · IN

Holders

Ownership

FIIs raised their stake +0.7pp QoQ

Jun 2026 quarter

Upgrade to see this quarter’s exact figures

Ownership by quarter

Promoter

— 0.0pp

Disclosure timeline

DISCLOSEDT+30
Groww Mutual Fund (scheme IB18)
Marksans Pharma Limited · NSE
3,804 sh · ₹12.26 L
Filed 30 Sept 2026AMFI portfolioview source
ACQUIREDT+30
Merrill Jean Saldanha
Marksans Pharma Limited · NSE
+63,273 sh · ₹0
Filed 17 Sept 2026SEBI Reg 7view source
ACQUIREDT+30
Marise Ann Saldanha
Marksans Pharma Limited · NSE
+20,000 sh · ₹0
Filed 17 Sept 2026SEBI Reg 7view source
ACQUIREDT+30
Schenelle Megan Saldanha
Marksans Pharma Limited · NSE
+1,45,000 sh · ₹0
Filed 17 Sept 2026SEBI Reg 7view source
REDUCEDT+30
Sandra Saldanha
Marksans Pharma Limited · NSE
−2,28,273 sh · ₹0
Filed 17 Sept 2026SEBI Reg 7view source
DISCLOSEDMonthly
Groww Mutual Fund (scheme IB18)
Marksans Pharma Limited · NSE
3,830 sh · ₹12.32 L
Filed 31 Aug 2026AMFI portfolioview source
REDUCEDStale
Microcurves Trading Private Limited
Marksans Pharma Limited · NSE
−43,49,697 sh · ₹136.32 Cr
Filed 12 Aug 2026NSE bulk dealview source
ACQUIREDStale
Microcurves Trading Private Limited
Marksans Pharma Limited · NSE
+43,49,697 sh · ₹136.25 Cr
Filed 12 Aug 2026NSE bulk dealview source
DISCLOSEDMonthly
Groww Mutual Fund (scheme NI)
Marksans Pharma Limited · NSE
3,812 sh · ₹9.85 L
Filed 31 Jul 2026AMFI portfolioview source

Announcements

The announcements library is part of Pro.

Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.

40 announcements on record for this company.

Part of Pro — upgrade to open